Elevated IL-6 levels in patients with HNSCC correlate with higher tumor stage, lymph node metastasis, increased proliferative tumor-activity, decreased immunologic response, and distinctive cachexia [7]. This evidence concerns the gene IL6 and head and neck squamous cell carcinoma.